Exhibit A

Big Pharma closing up shop in the UK to appease shareholders by cutting fixed costs, rolling out a hefty share buy-back program with future intent to pilfer rely on the R&D efforts of small firms, academia and... the government.  Moving from the development of drugs to... vitamins.

And the world becomes a better place for all.